307 related articles for article (PubMed ID: 17427960)
21. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
22. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
23. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR
Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
25. [Impact of glycogen synthase kinase-3β (GSK-3β) inhibitor on Wnt and NF-κB signal pathways in a rat model of diabetic nephropathy].
Zhou Y; Li L; Yu Y; Yang H; Yao H; Zhang Y; Zhang L; Deng C; Zhao L; Zhang Y; Song B
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):783-7. PubMed ID: 26888388
[TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
Hu Y; Gu X; Li R; Luo Q; Xu Y
J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase 3beta in the nucleus accumbens core mediates cocaine-induced behavioral sensitization.
Xu CM; Wang J; Wu P; Zhu WL; Li QQ; Xue YX; Zhai HF; Shi J; Lu L
J Neurochem; 2009 Dec; 111(6):1357-68. PubMed ID: 19799712
[TBL] [Abstract][Full Text] [Related]
28. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
29. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway.
Deng J; Xia W; Miller SA; Wen Y; Wang HY; Hung MC
Mol Carcinog; 2004 Mar; 39(3):139-46. PubMed ID: 14991743
[TBL] [Abstract][Full Text] [Related]
30. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.
Schwabe RF; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G204-11. PubMed ID: 12065308
[TBL] [Abstract][Full Text] [Related]
31. Involvement of glycogen synthase kinase-3β in arsenic trioxide-induced p21 expression.
Huang HS; Liu ZM; Cheng YL
Toxicol Sci; 2011 May; 121(1):101-9. PubMed ID: 21278055
[TBL] [Abstract][Full Text] [Related]
32. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.
Liu H; Ou S; Xiao X; Zhu Y; Zhou S
Am J Med Sci; 2015 Sep; 350(3):204-11. PubMed ID: 26226547
[TBL] [Abstract][Full Text] [Related]
33. Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation.
De Ketelaere A; Vermeulen L; Vialard J; Van De Weyer I; Van Wauwe J; Haegeman G; Moelans I
FEBS Lett; 2004 May; 566(1-3):60-4. PubMed ID: 15147869
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.
Dugo L; Abdelrahman M; Murch O; Mazzon E; Cuzzocrea S; Thiemermann C
Shock; 2006 May; 25(5):485-91. PubMed ID: 16680013
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase 3β in the basolateral amygdala is critical for the reconsolidation of cocaine reward memory.
Wu P; Xue YX; Ding ZB; Xue LF; Xu CM; Lu L
J Neurochem; 2011 Jul; 118(1):113-25. PubMed ID: 21592120
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis.
Götschel F; Kern C; Lang S; Sparna T; Markmann C; Schwager J; McNelly S; von Weizsäcker F; Laufer S; Hecht A; Merfort I
Exp Cell Res; 2008 Apr; 314(6):1351-66. PubMed ID: 18261723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
